Brain Cancer Trial, Recruiting NCT06313853 Sponsor: University of Rochester Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06313853
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • People aged 65 or older
  • People who have been diagnosed with Alzheimer's disease or a related form of dementia (including vascular dementia, Lewy body dementia, frontotemporal dementia, or dementia of unknown type)
  • People who have also been diagnosed with cancer of any type or stage
  • People who have an upcoming decision to be made about their cancer treatment or management, as confirmed by their cancer doctor
  • People who have a care partner (such as a family member or close support person) who is willing and able to take part in the study alongside them
  • People who can read and understand English, as the study sessions are delivered in English
  • People who are able to give their own informed consent to join the study, or who have a legally appointed representative who can give consent on their behalf

For care partners:

  • People aged 18 or over who support a patient taking part in the trial
  • People who can read and understand spoken English
  • People who are able to give their own informed consent to participate

For oncology clinicians:

  • Cancer specialists who are affiliated with the Wilmot Cancer Institute
  • Clinicians who do not plan to move or retire within the next two years

Who may not be able to join:

  • There are no listed exclusion criteria for patients, care partners, or oncology clinicians in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Allison Magnuson, University of Rochester

Phone: 585-602-5085

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2024
Est. completion
15 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Care Partner: Health Care Climate Questionnaire (HCCQ)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov